|
VPS33B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.42950000000675E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.336600E-03 |
| Normal-vs-Stage2 |
1.519030E-03 |
| Normal-vs-Stage3 |
2.7181999995296E-07 |
| Normal-vs-Stage4 |
3.620700E-04 |
| Stage1-vs-Stage2 |
1.002150E-01 |
| Stage1-vs-Stage3 |
2.962700E-04 |
| Stage1-vs-Stage4 |
3.979600E-02 |
| Stage2-vs-Stage3 |
3.801400E-01 |
| Stage2-vs-Stage4 |
9.194000E-01 |
| Stage3-vs-Stage4 |
3.952200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51733999999015E-05 |
| Normal-vs-AfricanAmerican |
3.430200E-01 |
| Normal-vs-Asian |
1.030250E-01 |
| Caucasian-vs-AfricanAmerican |
6.223500E-03 |
| Caucasian-vs-Asian |
1.682630E-03 |
| AfricanAmerican-vs-Asian |
7.492400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.67510000000215E-05 |
| Normal-vs-Female |
1.723980E-03 |
| Male-vs-Female |
5.808200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.080400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.043300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.06950000003481E-06 |
| Normal-vs-Age(81-100Yrs) |
6.223200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.933000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.324800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.740400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.489700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.275600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.772000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.916400E-01 |
| Normal-vs-Grade 2 |
4.696400E-03 |
| Normal-vs-Grade 3 |
2.04520000002262E-06 |
| Normal-vs-Grade 4 |
3.81750000000292E-05 |
| Grade 1-vs-Grade 2 |
2.957900E-02 |
| Grade 1-vs-Grade 3 |
1.436850E-03 |
| Grade 1-vs-Grade 4 |
3.601200E-03 |
| Grade 2-vs-Grade 3 |
2.973800E-02 |
| Grade 2-vs-Grade 4 |
2.082500E-02 |
| Grade 3-vs-Grade 4 |
3.704200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.212400E-04 |
| Normal-vs-ccB subtype |
2.45749999999711E-05 |
| ccA subtype-vs-ccB subtype |
1.679360E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.582940E-03 |
| Normal-vs-N1 |
1.038630E-01 |
| N0-vs-N1 |
9.228000E-01 |
|
|
